Vallerie McLaughlin, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Aerovate, Apollo, CVS/Caremark, L.L.C., Corvista, Gossamer Bio, Janssen, Keros, Liquidia, Merck, Morphic, Regeneron, Respira, Roivant, United Therapeutics
    Date added:
    01/06/2025
    Date updated:
    01/06/2025
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    PI-Aerovate, Enzyvant/Altavant, Gossamer-Bio, Keros, Sonovie, Sub-I Janssen, Merck/Aceleron
    Date added:
    01/06/2025
    Date updated:
    01/06/2025
Return to March 14, 2025 31st Advances in Pulmonary and Critical Care Medicine Conference